CJC-1295 DAC (Drug Affinity Complex) is a synthetic peptide used in peptide therapy. It’s a modified version of growth hormone-releasing hormone (GHRH), which stimulates the secretion of growth hormone (GH). CJC-1295 DAC has a unique feature that allows it to have a longer half-life compared to other forms of CJC-1295 because of the DAC component, which helps it bind to albumin in the bloodstream, extending its activity.
Here’s a brief overview of CJC-1295 DAC: